This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Sylvia Rita Vozari: Innovator in Neurodegenerative Disease Treatment
Introduction
Sylvia Rita Vozari is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. Her innovative work has led to the development of novel compounds that hold promise for improving patient outcomes.
Latest Patents
Sylvia Rita Vozari holds a patent for "Quinoline or quinoxaline derivatives for treating neurodegenerative diseases." This invention relates to compounds of Formula (I), which includes various chemical structures designed to target neurodegenerative conditions. The patent outlines the use of these compounds, their pharmaceutically acceptable salts, and their isomers or mixtures of isomers. The invention also details a process for preparing these compounds, emphasizing their potential therapeutic applications.
Career Highlights
Vozari is affiliated with the Centre National de la Recherche Scientifique, where she conducts her research. Her work has been instrumental in advancing the understanding of neurodegenerative diseases and developing effective treatments. With a focus on innovative solutions, she continues to contribute to the scientific community.
Collaborations
Sylvia has collaborated with notable colleagues, including Pierre Champy and Fanny Schmidt. These partnerships have enhanced her research efforts and expanded the impact of her inventions in the field.
Conclusion
Sylvia Rita Vozari's contributions to the treatment of neurodegenerative diseases through her innovative patents highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
